When "Flawed" Translates into "Flood": The Unproven Association Between Cancer Incidence and Glargine Insulin Therapy

被引:2
作者
de Miguel-Yanes, Jose M. [1 ,2 ]
Meigs, James B. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Med, Boston, MA 02114 USA
[2] Hosp Gregorio Maranon, Dept Internal Med, Madrid, Spain
关键词
MALIGNANCIES; ANALOGS; RISK;
D O I
10.1634/theoncologist.2009-0278
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1175 / 1177
页数:3
相关论文
共 14 条
[1]   The long acting human insulin analog HOE 901:: Characteristics of insulin signalling in comparison to Asp(B10) and regular insulin [J].
Berti, L ;
Kellerer, M ;
Bossenmaier, B ;
Seffer, E ;
Seipke, G ;
Häring, HU .
HORMONE AND METABOLIC RESEARCH, 1998, 30 (03) :123-129
[2]  
Christensen R, 2008, LANCET, V371, P558
[3]   Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group [J].
Colhoun, H. M. .
DIABETOLOGIA, 2009, 52 (09) :1755-1765
[4]   The influence of glucose-lowering therapies on cancer risk in type 2 diabetes [J].
Currie, C. J. ;
Poole, C. D. ;
Gale, E. A. M. .
DIABETOLOGIA, 2009, 52 (09) :1766-1777
[5]   Putting Insulin Glargine and Malignancies into Perspective [J].
Ehninger, Gerhard ;
Schmidt, Alexander H. .
ONCOLOGIST, 2009, 14 (12) :1169-1174
[6]   Insulin glargine and cancer: another side to the story? [J].
Gale, Edwin A. M. .
LANCET, 2009, 374 (9689) :521-521
[7]  
GROUVEN U, 2009, DIABETOLOGIA 1024, DOI DOI 10.1007/S00125-009-1582-6
[8]   Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study [J].
Hemkens, L. G. ;
Grouven, U. ;
Bender, R. ;
Guenster, C. ;
Gutschmidt, S. ;
Selke, G. W. ;
Sawicki, P. T. .
DIABETOLOGIA, 2009, 52 (09) :1732-1744
[9]   Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes [J].
Holman, Rury R. ;
Farmer, Andrew J. ;
Davies, Melanie J. ;
Levy, Jonathan C. ;
Darbyshire, Julie L. ;
Keenan, Joanne F. ;
Paul, Sanjoy K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18) :1736-1747
[10]   Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis [J].
Home, Philip D. ;
Pocock, Stuart J. ;
Beck-Nielsen, Henning ;
Gomis, Ramon ;
Hanefeld, Markolf ;
Jones, Nigel P. ;
Komajda, Michel ;
McMurray, John J. V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :28-38